Browsing by Author "Holme, Pal Andre"
Now showing items 1-1 of 1
-
Once-weekly prophylaxis with glycoPEGylated recombinant factor VIII (N8-GP) in severe haemophilia A: Safety and efficacy results from pathfinder 2 (randomized phase III trial)
Curry, Nicola; Albayrak, Canan; Escobar, Miguel; Holme, Pal Andre; Kearney, Susan; Klamroth, Robert; Lentz, Steven R. (Wiley, 2019)Introduction Turoctocog alfa pegol (N8-GP) is a site-specific, 40 kDa glycoPEGylated recombinant factor VIII (FVIII) product with an extended half-life. The comprehensive main phase of the pivotal pathfinder 2 trial showed ...